P

Inventor

NICHOLSON MICHAEL G

US19 patents
⚠️ This page may combine multiple inventors who share the name “NICHOLSON MICHAEL G”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

PREC BIOSCIENCES INC

18 patents
US9889160B2Feb 13, 2018

Genetically-modified cells comprising a modified human T cell receptor alpha constant region gene

PREC BIOSCIENCES INC65 citations98
US9889161B2Feb 13, 2018

Genetically-modified cells comprising a modified human T cell receptor alpha constant region gene

PREC BIOSCIENCES INC27 citations97
US10093899B1Oct 9, 2018

Genetically-modified cells comprising a modified human T cell receptor alpha constant region gene

PREC BIOSCIENCES INC8 citations92
US10093900B2Oct 9, 2018

Genetically-modified cells comprising a modified human T cell receptor alpha constant region gene

PREC BIOSCIENCES INC15 citations92
US9993501B2Jun 12, 2018

Genetically-modified cells comprising a modified human T cell receptor alpha constant region gene

PREC BIOSCIENCES INC11 citations92
US9993502B1Jun 12, 2018

Genetically-modified cells comprising a modified human T cell receptor alpha constant region gene

PREC BIOSCIENCES INC16 citations92
US9969975B1May 15, 2018

Genetically-modified cells comprising a modified human T cell receptor alpha constant region gene

PREC BIOSCIENCES INC13 citations92
US9950011B1Apr 24, 2018

Genetically-modified cells comprising a modified human T cell receptor alpha constant region gene

PREC BIOSCIENCES INC14 citations92
US9950010B1Apr 24, 2018

Genetically-modified cells comprising a modified human T cell receptor alpha constant region gene

PREC BIOSCIENCES INC14 citations92
US10799535B2Oct 13, 2020

Engineered meganucleases with recognition sequences found in the human T cell receptor alpha constant region gene

PREC BIOSCIENCES INC5 citations84
US10603363B2Mar 31, 2020

Treatment of retinitis pigmentosa using engineered meganucleases

PREC BIOSCIENCES INC3 citations73
US9822381B2Nov 21, 2017

Methods and products for producing engineered mammalian cell lines with amplified transgenes

PREC BIOSCIENCES INC2 citations73
US12595469B2Apr 7, 2026

Treatment of retinitis pigmentosa using improved engineered meganucleases

PREC BIOSCIENCES INC0 citations62
US11266693B2Mar 8, 2022

Nucleic acids encoding engineered meganucleases with recognition sequences found in the human T cell receptor alpha constant region gene

PREC BIOSCIENCES INC0 citations62
US11268065B2Mar 8, 2022

Genetically-modified cells comprising a modified human T cell receptor alpha constant region gene

PREC BIOSCIENCES INC0 citations62
US11278632B2Mar 22, 2022

Engineered nucleases useful for treatment of hemophilia A

PREC BIOSCIENCES INC0 citations61
US10758595B2Sep 1, 2020

Treatment of retinitis pigmentosa using engineered meganucleases

PREC BIOSCIENCES INC0 citations52
US10662440B2May 26, 2020

Self-limiting viral vectors encoding nucleases

PREC BIOSCIENCES INC0 citations52

VIRO INTERNAT CORP N

1 patent